Theratechnologies Inc (TH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Theratechnologies Inc (TH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10125
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theratechnologies Inc (Theratechnologies) is a pharmaceutical company that focuses on the discovery and development of drugs for metabolic disorders. The company develops therapeutic peptide products, with an emphasis on growth releasing factor (GRF) peptides. Its lead products include Egrifta (tesamorelin for injection) is indicated to reduce excess abdominal fat in HIV-infected patients with lipodystrophy; and Trogarzo, indicated for the treatment of human immunodeficiency virus type 1 infection in the US. The proprietary technologies of Theratechnologies include long acting peptides, a peptide stabilization technology to increase target protein’s resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.

Theratechnologies Inc (TH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theratechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Theratechnologies Acquires Commercial Rights to Ibalizumab from TaiMed Biologics 10
Partnerships 12
Grupo Praxis Pharma Enters into Commercialization Agreement with Theratechnologies 12
Theratechnologies Enters into Co-Marketing Agreement with TaiMed Biologics 13
Theratechnologies Enters into Commercialization Agreement with BL&H 14
Licensing Agreements 15
Theratechnologies Enters into Licensing Agreement with AOP Orphan Pharma for Egrifta 15
Theratechnologies Enters Into Licensing Agreement With Actelion Pharma For Lipodystrophy Drug 16
Equity Offering 17
Theratechnologies Raises USD12 Million in Private Placement of Shares 17
Theratechnologies Raises USD8.5 Million in Public Offering of Units 19
Debt Offering 20
Theratechnologies Raises USD57.5 Million in Public Offering of 5.75% Notes Due 2023 20
Theratechnologies Inc – Key Competitors 21
Theratechnologies Inc – Key Employees 22
Theratechnologies Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Oct 04, 2018: Theratechnologies announces financial results for the third quarter of 2018 24
Jul 05, 2018: Theratechnologies Announces Financial Results for the Second Quarter of 2018 27
Apr 05, 2018: Theratechnologies Announces Financial Results for First Quarter of 2018 30
Feb 07, 2018: Theratechnologies Announces Financial Results for Fiscal Year 2017 32
Oct 05, 2017: Theratechnologies Announces Financial Results for Third Quarter of 2017 35
Jul 12, 2017: Theratechnologies Announces Financial Results for Second Quarter of 2017 38
Apr 06, 2017: Theratechnologies Announces Financial Results for First Quarter of 2017 41
Feb 08, 2017: Theratechnologies Announces Financial Results for Fiscal Year 2016 44
Corporate Communications 47
Oct 15, 2018: Theratechnologies names New Board Member 47
May 16, 2017: Shareholders elect new Board member during Theratechnologies’ annual meeting 48
Product News 49
07/24/2017: Theratechnologies Announces New Findings with Investigational Antiretroviral EGRIFTA (tesamorelin for injection) 49
03/01/2017: Theratechnologies Holds Investment Community Meeting And Provides Updated Financial Guidance For Its Fiscal Year 2017 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Theratechnologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theratechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theratechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theratechnologies Acquires Commercial Rights to Ibalizumab from TaiMed Biologics 10
Grupo Praxis Pharma Enters into Commercialization Agreement with Theratechnologies 12
Theratechnologies Enters into Co-Marketing Agreement with TaiMed Biologics 13
Theratechnologies Enters into Commercialization Agreement with BL&H 14
Theratechnologies Enters into Licensing Agreement with AOP Orphan Pharma for Egrifta 15
Theratechnologies Enters Into Licensing Agreement With Actelion Pharma For Lipodystrophy Drug 16
Theratechnologies Raises USD12 Million in Private Placement of Shares 17
Theratechnologies Raises USD8.5 Million in Public Offering of Units 19
Theratechnologies Raises USD57.5 Million in Public Offering of 5.75% Notes Due 2023 20
Theratechnologies Inc, Key Competitors 21
Theratechnologies Inc, Key Employees 22
Theratechnologies Inc, Subsidiaries 23

List of Figures
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Theratechnologies Inc (TH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WS Atkins Plc:戦略・SWOT・企業財務分析
    WS Atkins Plc - Strategy, SWOT and Corporate Finance Report Summary WS Atkins Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Software AG:企業の戦略・SWOT・財務分析
    Software AG - Strategy, SWOT and Corporate Finance Report Summary Software AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Siem Offshore Inc (SIOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. The company offers shipbuilding, ordering and delivery of new vessels, acquisition of modern sec …
  • IMI plc:企業の戦略・SWOT・財務分析
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safet …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Kinpo Electronics Inc (2312):企業の財務・戦略的SWOT分析
    Kinpo Electronics Inc (2312) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Thales Holdings UK Plc:企業の戦略・SWOT・財務情報
    Thales Holdings UK Plc - Strategy, SWOT and Corporate Finance Report Summary Thales Holdings UK Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • EnBW Energie Baden-Wurttemberg AG (EBK):電力:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Wolverine Power Supply Cooperative Inc:企業の戦略的SWOT分析
    Wolverine Power Supply Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • NorthWestern Corp:企業の発電所・SWOT分析2018
    NorthWestern Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Lenovo Group Limited:企業のM&A・事業提携・投資動向
    Lenovo Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lenovo Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Avista Corporation:企業の戦略・SWOT・財務分析
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Navios Maritime Holdings Inc.:企業のM&A・事業提携・投資動向
    Navios Maritime Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆